Series B - Alloy Therapeutics - 2020-06-05 - Crunchbase

Alloy Therapeutics raised $11250000 on 2020-06-05 in Series B. There is no recent news or activity for this profile.

CouponFollow Extension

$11250000
OFF

Series B - Alloy Therapeutics - 2020-06-05 - Crunchbase

4 weeks from now

Alloy Therapeutics raised $11250000 on 2020-06-05 in Series B. There is no recent news or activity for this profile.

crunchbase.com

$70
OFF

The Week’s 10 Biggest Funding Rounds: Biotech Goes

4 weeks from now

Apr 28, 2023 · Founded in 2020, the company has raised more than $70 million, per Crunchbase. 9. Antiva Biosciences , $53M, biotech: South San Francisco-based Antiva Biosciences — a …

crunchbase.com

$117
OFF

Alloy Therapeutics - CB Insights

4 weeks from now

Oct 3, 2022 · Funding, Valuation & Revenue. 3 Fundings. Alloy Therapeutics has raised $117M over 3 rounds.. Alloy Therapeutics's latest funding round was a Series D for $42M on October …

cbinsights.com

$42
OFF

Alloy Therapeutics Raises $42 Million In Series D Financing

4 weeks from now

BOSTON, MA; October 03, 2022—Alloy Therapeutics, a biotechnology ecosystem company, has closed $42 million in Series D financing led by its existing investors 8VC and Mubadala Capital …

alloytx.com

$100
OFF

These Are The Industries Where Series B Funding Is Growing Fastest

4 weeks from now

Nov 29, 2021 · For financial services subsectors, a total of 14 U.S. companies closed Series B rounds of $100 million or more this year. Top Series B recipients included Recharge ($227 …

crunchbase.com

$40
OFF

Alloy Raises $40 Million Series B To Help Banks & Fintechs Avoid Fraud

4 weeks from now

Sep 16, 2020 · Alloy, which has built an identity operating system for the financial services industry, announced Wednesday a $40 million Series B raise.. Canapi Ventures led the …

finledger.com

$42000000
OFF

Series D - Alloy Therapeutics - 2022-10-03 - Crunchbase

4 weeks from now

Oct 4, 2022 · Alloy Therapeutics raised $42000000 on 2022-10-03 in Series D. Mubadala Capital Ventures Mubadala Ventures is the venture capital arm of Mubadala that focuses on advanced …

crunchbase.com

$75
OFF

Alloy Therapeutics Raises $75 Million In Series C Financing To …

4 weeks from now

Apr 2, 2021 · BOSTON--(BUSINESS WIRE)--Alloy Therapeutics, a biotechnology ecosystem company empowering the global scientific community to make better medicines together, …

businesswire.com

$40000000
OFF

Series B - Alloy - 2020-09-16 - Crunchbase Funding Round Profile

4 weeks from now

Alloy raised $40000000 on 2020-09-16 in Series B. Canapi Ventures Canapi Ventures is a venture capital firm that invests in early to growth-stage fintech companies that deploy …

crunchbase.com

$75000000
OFF

Series C - Alloy Therapeutics - 2021-04-02 - Crunchbase

4 weeks from now

Apr 2, 2021 · Alloy Therapeutics raised $75000000 on 2021-04-02 in Series C. Presight Capital Presight Capital is a venture capital firm investing in the most ambitious founders across …

crunchbase.com

$139380010
OFF

Series B - Apollo Therapeutics - 2021-06-17 - Crunchbase

4 weeks from now

Jun 17, 2021 · Apollo Therapeutics raised $139380010 on 2021-06-17 in Series B. Patient Square Capital Patient Square Capital is a health care investment firm that will make investments by …

crunchbase.com

FAQs about Series B - Alloy Therapeutics - 2020-06-05 - Crunchbase Coupon?

How many investors has alloy Therapeutics raised?

Alloy Therapeutics is funded by 11 investors. 8VC and Presight Capital are the most recent investors. Alloy Therapeutics has raised a total of $128.3M in funding over 3 rounds. Their latest funding was raised on Oct 3, 2022 from a Series D round. Which funding types raised the most money? How much funding has this organization raised over time? ...

What is alloy Therapeutics?

Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services. ...

Who will join alloy Therapeutics' Board of directors?

As part of the Series C financing, Fabian Hansen, founder and Managing Director of US venture capital fund Presight Capital, will join as a member of Alloy Therapeutics’ board of directors. In addition, Alaa Halawa, co-head of Mubadala Capital’s US Ventures business, will join as a board observer. ...

Are investors backing fewer Series B deals in 2023?

So far in 2023, Crunchbase data shows investors are backing fewer big rounds. There were just six Series B deals of $100 million or more to date this year, an average of fewer than one per week. In 2022, by comparison, there were 90 such rounds, or almost two per week. Still, we are seeing some mega-sized Series B deals this year. ...

What are the biggest Series B investments in 2024?

Notably, several of the biggest Series B investments this year went to companies that closed their prior round not too long ago. The most high profile example is Elon Musk ’s xAI. The generative AI startup closed the largest Series B of 2024 — a $6 billion financing — six months after raising its previous round. ...

What happened to Series B investment in 2022?

Per Crunchbase data, Series B investment in the second half of 2022 was down over 60% from the year-ago period. For a sense of how far things have fallen, we chart out Series B deal counts and funding for the past nine quarters below. Why Series B? So why single out Series B for scrutiny? ...